The phosphatidylinositol 3-kinase (PI3K)/AKT/mammalian target of rapamycin and the Raf/MEK/ERK signaling are the major mediators of several receptor tyrosine kinase pathways involved in HCC progression. This evidence concerns the gene AKT1 and hepatocellular carcinoma.